Bone Scintigraphy and Densitometry in Symptomatic Haemodialysis Bone Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Bone scintigraphy and densitometry (iodine-125 photon absorptiometry) were performed in eight patients with symptomatic haemodialysis bone disease. The bone scintiscan showed either hot spots or hyperactivity as a feature of metabolic bone disease. The bone density (BMC/W) was reduced, but could not be distinguished from the degree of demineralisation found in asymptomatic patients on long-term haemodialysis. Therefore, bone density measurements require critical interpretation. Complementary bone scintigraphy should be used in symptomatic haemodialysis bone disease for assessing the extent of the disease.
References
1.
Alberts C
. I-125 photon absorptiometric analysis of bone density in patients with regular dialysis treatment. Eur J Nucl Med. 1979; 4(1):27-31.
DOI: 10.1007/BF00257566.
View
2.
de Graaf P, Schicht I, Pauwels E, te Velde J, de GRAEFF J
. Bone scintigraphy in renal osteodystrophy. J Nucl Med. 1978; 19(12):1289-96.
View
3.
Fogelman I, McKillop J, Bessent R, Boyle I, Turner J, Greig W
. The role of bone scanning in osteomalacia. J Nucl Med. 1978; 19(3):245-8.
View
4.
Sy W, Mittal A
. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol. 1975; 48(575):878-84.
DOI: 10.1259/0007-1285-48-575-878.
View
5.
Cameron J, Sorenson J
. MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD. Science. 1963; 142(3589):230-2.
DOI: 10.1126/science.142.3589.230.
View